These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7664172)

  • 1. Transport of recombinant human CD4-immunoglobulin G across the human placenta: pharmacokinetics and safety in six mother-infant pairs in AIDS clinical trial group protocol 146.
    Shearer WT; Duliege AM; Kline MW; Hammill H; Minkoff H; Ammann AJ; Chen S; Izu A; Mordenti J
    Clin Diagn Lab Immunol; 1995 May; 2(3):281-5. PubMed ID: 7664172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase 1 study of recombinant human CD4-immunoglobulin G therapy of patients with AIDS and AIDS-related complex.
    Hodges TL; Kahn JO; Kaplan LD; Groopman JE; Volberding PA; Amman AJ; Arri CJ; Bouvier LM; Mordenti J; Izu AE
    Antimicrob Agents Chemother; 1991 Dec; 35(12):2580-6. PubMed ID: 1810192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy with recombinant human soluble CD4-immunoglobulin G and zidovudine in patients with HIV infection: a phase I study.
    Meng TC; Fischl MA; Cheeseman SH; Spector SA; Resnick L; Boota A; Petrakis T; Wright B; Richman DD
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Feb; 8(2):152-60. PubMed ID: 7834398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The safety and pharmacokinetics of recombinant soluble CD4 (rCD4) in subjects with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. A phase 1 study.
    Kahn JO; Allan JD; Hodges TL; Kaplan LD; Arri CJ; Fitch HF; Izu AE; Mordenti J; Sherwin JE; Groopman JE
    Ann Intern Med; 1990 Feb; 112(4):254-61. PubMed ID: 2297204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety, pharmacokinetics, and antiviral response of CD4-immunoglobulin G by intravenous bolus in AIDS and AIDS-related complex.
    Collier AC; Coombs RW; Katzenstein D; Holodniy M; Gibson J; Mordenti J; Izu AE; Duliege AM; Ammann AJ; Merigan T
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Oct; 10(2):150-6. PubMed ID: 7552478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral studies of mothers with human immunodeficiency virus infection at delivery and their infants in the first 3 days of life.
    Sison AV; Brandt CD; Rakusan TA; Wientzen R; Fuccillo DA; Sever JL
    Pediatr AIDS HIV Infect; 1996 Oct; 7(5):325-30. PubMed ID: 11361490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between an IgG3 polymorphism in the binding domain for FcRn, transplacental transfer of malaria-specific IgG3, and protection against Plasmodium falciparum malaria during infancy: A birth cohort study in Benin.
    Dechavanne C; Dechavanne S; Sadissou I; Lokossou AG; Alvarado F; Dambrun M; Moutairou K; Courtin D; Nuel G; Garcia A; Migot-Nabias F; King CL
    PLoS Med; 2017 Oct; 14(10):e1002403. PubMed ID: 28991911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for extended age dependent maternal immunity in infected children: mother to child transmission of HIV infection and potential interventions including sulfatides of the human fetal adnexa and complementary or alternative medicines.
    Bhargav H; Huilgol V; Metri K; Sundell IB; Tripathi S; Ramagouda N; Jadhav M; Raghuram N; Ramarao NH; Koka PS
    J Stem Cells; 2012; 7(3):127-53. PubMed ID: 23619381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a recombinant CD4-IgG on in vitro T helper cell function: data from a phase I/II study of patients with AIDS.
    Clerici M; Yarchoan R; Blatt S; Hendrix CW; Ammann AJ; Broder S; Shearer GM
    J Infect Dis; 1993 Oct; 168(4):1012-6. PubMed ID: 8376811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4 immunoadhesins in anti-HIV therapy: new developments.
    Chamow SM; Duliege AM; Ammann A; Kahn JO; Allen JD; Eichberg JW; Byrn RA; Capon DJ; Ward RH; Ashkenazi A
    Int J Cancer Suppl; 1992; 7():69-72. PubMed ID: 1428410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic implication of specific immunoglobulin G patterns of children born to HIV-infected mothers.
    Broliden PA; Moschese V; Ljunggren K; Rosen J; Fundaro C; Plebani A; Jondal M; Rossi P; Wahren B
    AIDS; 1989 Sep; 3(9):577-82. PubMed ID: 2551341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of HIV-1 IIIB infection in chimpanzees by CD4 immunoadhesin.
    Ward RH; Capon DJ; Jett CM; Murthy KK; Mordenti J; Lucas C; Frie SW; Prince AM; Green JD; Eichberg JW
    Nature; 1991 Aug; 352(6334):434-6. PubMed ID: 1907354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological properties of a CD4 immunoadhesin.
    Byrn RA; Mordenti J; Lucas C; Smith D; Marsters SA; Johnson JS; Cossum P; Chamow SM; Wurm FM; Gregory T; Groopman JE; Capon DJ
    Nature; 1990 Apr; 344(6267):667-70. PubMed ID: 1970124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant CD4-selected human immunodeficiency virus type 1 variants with reduced gp120 affinity for CD4 and increased cell fusion capacity.
    McKeating J; Balfe P; Clapham P; Weiss RA
    J Virol; 1991 Sep; 65(9):4777-85. PubMed ID: 1870202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: phase I acquired immunodeficiency syndrome clinical trials group study (protocol 082). Zidovudine Collaborative Working Group.
    O'Sullivan MJ; Boyer PJ; Scott GB; Parks WP; Weller S; Blum MR; Balsley J; Bryson YJ
    Am J Obstet Gynecol; 1993 May; 168(5):1510-6. PubMed ID: 8098905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro production of HIV-specific antibody in children at risk of AIDS.
    Amadori A; de Rossi A; Giaquinto C; Faulkner-Valle G; Zacchello F; Chieco-Bianchi L
    Lancet; 1988 Apr; 1(8590):852-4. PubMed ID: 2895365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.
    Connor EM; Sperling RS; Gelber R; Kiselev P; Scott G; O'Sullivan MJ; VanDyke R; Bey M; Shearer W; Jacobson RL
    N Engl J Med; 1994 Nov; 331(18):1173-80. PubMed ID: 7935654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The epidemiology of perinatal transmission of HIV.
    Ryder RW; Hassig SE
    AIDS; 1988; 2 Suppl 1():S83-9. PubMed ID: 3147684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obstetric and perinatal consequences of human immunodeficiency virus (HIV) infection: a review.
    Peckham CS; Senturia YD; Ades AE
    Br J Obstet Gynaecol; 1987 May; 94(5):403-7. PubMed ID: 3555606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.